-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-BioArctic Says Rolling sBLA Initiated To The U.S. FDA For Leqembi As Subcutaneous Starting Dose For Treatment Of Early Alzheimer's Disease Under Fast Track Status

Reuters·09/02/2025 23:33:05

Please log in to view news